Mouse CD160 is a MHC I-specific IG-like receptor and positively or negatively regulates NK cell activation, depending on stimuli.
| Institute |
|---|
| BC Cancer |
| Cat. #: | 157773 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Immunology |
| Application: | FACS ; ELISA ; IP ; WB |
| Target: | CD160 |
| Reactivity: | Mouse |
| Host: | Rat |
| Class: | Monoclonal |
| Alternate name: | NK28; NK1; BY55 |
|---|---|
| Product description: | CD160 is found on cytotoxic lymphocytes – NK, NKT, and activated CD8+ T cells. Mouse CD160 is a MHC I-specific IG-like receptor and positively or negatively regulates NK cell activation, depending on stimuli. |
| Conjugation: | Unconjugated |
| Molecular weight: | 20 kDa |
| Immunogen: | Mouse CD160 fused to FC |
| Immunogen Uniprot ID: | CD160_MOUSE |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | CD160 is found on cytotoxic lymphocytes – NK, NKT, and activated CD8+ T cells. Mouse CD160 is a MHC I-specific IG-like receptor and positively or negatively regulates NK cell activation, depending on stimuli. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Maeda et al. 2005. J Immunol. 175(7):4426-32. PMID: 16177084. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151025 | Anti-Vascular endothelium [10] |
Key Info
Anti-Vascular endothelium [10]
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
| 151038 | Anti-Cytochrome P450 4A2, 4A3 [Clo4] |
Key Info
Anti-Cytochrome P450 4A2, 4A3 [Clo4]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.